author-photo

Jian Zhu

Takeda Pharmaceutical Company

4

Papers

48

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

A Novel Framework for Bayesian Response-Adaptive Randomization

2019
Show All
- Source
- Cite
- Save
Citations (0)
Antitumor activity of TAK-788 in NSCLC with EGFR exon 20 insertions.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (44)
P1.01-127 Antitumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 in NSCLC with EGFR Exon 20 Insertions

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (3)
MO2-15-1 [Encore]Antitumor activity of TAK-788 in NSCLC With EGFR exon 20 insertions

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (1)